company background image
BGT logo

Bio-Gene Technology ASX:BGT Stock Report

Last Price

AU$0.072

Market Cap

AU$14.1m

7D

20.0%

1Y

-10.0%

Updated

28 Mar, 2024

Data

Company Financials

Bio-Gene Technology Limited

ASX:BGT Stock Report

Market Cap: AU$14.1m

BGT Stock Overview

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia.

BGT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Bio-Gene Technology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bio-Gene Technology
Historical stock prices
Current Share PriceAU$0.072
52 Week HighAU$0.13
52 Week LowAU$0.038
Beta0.35
1 Month Change63.64%
3 Month Change20.00%
1 Year Change-10.00%
3 Year Change-46.67%
5 Year Change-25.77%
Change since IPO-64.00%

Recent News & Updates

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Shareholder Returns

BGTAU ChemicalsAU Market
7D20.0%0.6%1.5%
1Y-10.0%-4.9%11.6%

Return vs Industry: BGT underperformed the Australian Chemicals industry which returned -4.9% over the past year.

Return vs Market: BGT underperformed the Australian Market which returned 11.6% over the past year.

Price Volatility

Is BGT's price volatile compared to industry and market?
BGT volatility
BGT Average Weekly Movement14.8%
Chemicals Industry Average Movement10.1%
Market Average Movement8.7%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: BGT's share price has been volatile over the past 3 months.

Volatility Over Time: BGT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1995n/aTim Groganhttps://www.bio-gene.com.au

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage.

Bio-Gene Technology Limited Fundamentals Summary

How do Bio-Gene Technology's earnings and revenue compare to its market cap?
BGT fundamental statistics
Market capAU$14.10m
Earnings (TTM)-AU$2.63m
Revenue (TTM)AU$167.99k

86.3x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BGT income statement (TTM)
RevenueAU$167.99k
Cost of RevenueAU$323.57k
Gross Profit-AU$155.58k
Other ExpensesAU$2.48m
Earnings-AU$2.63m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.013
Gross Margin-92.61%
Net Profit Margin-1,568.35%
Debt/Equity Ratio0%

How did BGT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.